Protara Therapeutics, Inc. (TARA) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $59.00K; Additional Paid in CapitalUSD $503.48M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-363.00K; Retained Earnings (Accumulated Deficit)USD $-341.87M.
- 2026-03-31: Common Stock, Value, IssuedUSD $55.00K; Additional Paid in CapitalUSD $501.72M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-364.00K; Retained Earnings (Accumulated Deficit)USD $-320.20M.
- 2025-12-31: Common Stock, Value, IssuedUSD $54.00K; Additional Paid in CapitalUSD $498.69M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $90.00K; Retained Earnings (Accumulated Deficit)USD $-302.42M.
- 2025-09-30: Common Stock, Value, IssuedUSD $39.00K; Additional Paid in CapitalUSD $417.22M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $143.00K; Retained Earnings (Accumulated Deficit)USD $-285.11M.
Protara Therapeutics, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD | Preferred Stock, Value, Issued USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Other USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $59.00K | $503.48M | $-363.00K | $-341.87M | $161.31M | 3 month · $1.09M | 3 month · $294.00K | (m) | (m) | (m) | (m) |
| 2026-03-31 | $55.00K | $501.72M | $-364.00K | $-320.20M | $181.21M | 3 month · $1.04M | 3 month · $317.00K | (m) | (m) | (m) | (m) |
| 2025-12-31 | $54.00K | $498.69M | $90.00K | $-302.42M | $196.41M | 12 month · $3.14M | 12 month · $685.00K | (m) | (m) | (m) | (m) |
| 2025-09-30 | $39.00K | $417.22M | $143.00K | $-285.11M | $132.29M | 3 month · $851.00K | 3 month · $196.00K | (m) | (m) | (m) | (m) |
| 2025-06-30 | $39.00K | $416.16M | $77.00K | $-271.85M | $144.42M | 3 month · $736.00K | 3 month · $167.00K | (m) | (m) | (m) | (m) |
| 2025-03-31 | $39.00K | $415.25M | $89.00K | $-256.89M | $158.48M | 3 month · $712.00K | 3 month · $121.00K | (m) | (m) | (m) | (m) |
| 2024-12-31 | $35.00K | $412.08M | $2.00K | $-244.98M | $167.13M | 12 month · $3.65M | 12 month · $480.00K | (m) | (m) | (m) | (m) |
| 2024-09-30 | $21.00K | $313.95M | $29.00K | $-232.21M | $81.79M | 3 month · $822.00K | 3 month · $109.00K | (m) | (m) | (m) | (m) |
| 2024-06-30 | $21.00K | $313.02M | (m) | $-220.99M | $92.05M | 3 month · $953.00K | 3 month · $111.00K | (m) | (m) | (m) | (m) |
| 2024-03-31 | $11.00K | $269.88M | $-1.00K | $-211.48M | $58.41M | 3 month · $1.07M | 3 month · $151.00K | (m) | (m) | (m) | (m) |
| 2023-12-31 | $11.00K | $268.73M | $-31.00K | $-200.38M | $68.32M | 12 month · $4.88M | 12 month · $1.21M | (m) | (m) | (m) | (m) |
| 2023-09-30 | $11.00K | $267.27M | $-165.00K | $-190.16M | $76.96M | 3 month · $1.17M | 3 month · $275.00K | (m) | (m) | (m) | (m) |
| 2023-06-30 | $11.00K | $265.85M | $-336.00K | $-180.30M | $85.22M | 3 month · $1.29M | 3 month · $326.00K | (m) | (m) | (m) | (m) |
| 2023-03-31 | $11.00K | $264.24M | $-469.00K | $-169.01M | $94.77M | 3 month · $1.26M | 3 month · $314.00K | (m) | 3 month · $314.00K | (m) | (m) |
| 2022-12-31 | $11.00K | $262.72M | $-688.00K | $-159.96M | $102.08M | (m) | (m) | (m) | 12 month · $1.27M | (m) | (m) |
| 2022-09-30 | $11.00K | $261.29M | $-1.13M | $-121.00M | $139.18M | (m) | (m) | (m) | 3 month · $287.00K | (m) | (m) |
| 2022-06-30 | $11.00K | $259.88M | $-1.12M | $-113.31M | $145.46M | (m) | (m) | (m) | 3 month · $390.00K | (m) | (m) |
| 2022-03-31 | $11.00K | $257.93M | $-942.00K | $-104.77M | $152.24M | (m) | (m) | (m) | 3 month · $314.00K | (m) | (m) |
| 2021-12-31 | $11.00K | $256.13M | $-211.00K | $-94.01M | $161.91M | (m) | (m) | (m) | 12 month · $4.52M | (m) | (m) |
| 2021-09-30 | $11.00K | $254.22M | $-39.00K | $-83.78M | $170.41M | (m) | (m) | (m) | 3 month · $1.31M | (m) | (m) |
| 2021-06-30 | $11.00K | $251.50M | $-101.00K | $-73.01M | $178.41M | (m) | (m) | (m) | 3 month · $1.36M | (m) | (m) |
| 2021-03-31 | $11.00K | $248.50M | $-164.00K | $-60.23M | $188.13M | (m) | (m) | (m) | 3 month · $1.30M | (m) | (m) |
| 2020-12-31 | $11.00K | $245.99M | (m) | $-46.76M | $199.24M | (m) | (m) | (m) | 12 month · $3.39M | 12 month · $6.36M | (m) |
| 2020-09-30 | $10.52K | $232.57M | (m) | $-37.95M | $194.63M | (m) | (m) | $8.00 | 3 month · $1.47M | 3 month · $1.31M | (m) |
| 2020-06-30 | $5.84K | $89.41M | (m) | $-29.98M | $59.43M | (m) | (m) | $4.00 | 3 month · $514.05K | 3 month · $1.31M | (m) |
| 2020-03-31 | $5.84K | $87.58M | (m) | $-22.84M | $64.74M | (m) | (m) | $4.00 | 3 month · $368.13K | 3 month · $2.43M | (m) |
| 2019-12-31 | $3.00K | $10.65M | $3.00K | $-12.78M | $-2.13M | (m) | (m) | (m) | 12 month · $313.00K | 12 month · $36.00K | (m) |
| 2019-09-30 | $19.00K | $210.68M | $2.00K | $-223.85M | $284.91K | (m) | (m) | (m) | 3 month · $116.64K | 3 month · $22.50K | (m) |
| 2019-06-30 | $19.00K | $210.59M | $4.00K | $-222.32M | $2.00M | (m) | (m) | (m) | 3 month · $79.96K | 3 month · $22.50K | (m) |
| 2019-03-31 | $19.00K | $210.49M | $3.00K | $-217.00M | $3.33M | (m) | (m) | (m) | 3 month · $54.38K | 3 month · $22.50K | (m) |
| 2018-12-31 | $19.00K | $209.38M | $5.00K | $-210.47M | $4.78M | (m) | (m) | (m) | 12 month · $3.43M | (m) | (m) |
| 2018-09-30 | $19.00K | $208.54M | $4.00K | $-205.21M | $24.87M | (m) | (m) | (m) | 3 month · $904.00K | (m) | (m) |
| 2018-06-30 | $18.00K | $204.78M | $1.00K | $-200.70M | $25.62M | (m) | (m) | $0.00 | 3 month · $922.00K | (m) | (m) |
| 2018-03-31 | $18.00K | $203.77M | $-4.00K | $-195.82M | $29.49M | (m) | (m) | $0.00 | 3 month · $821.00K | (m) | (m) |
| 2017-12-31 | $18.00K | $202.95M | $-14.00K | $-189.74M | $34.74M | (m) | (m) | $0.00 | 12 month · $3.23M | (m) | 12 month · $108.00K |
| 2017-09-30 | $18.00K | $202.11M | $-7.00K | $-184.19M | $39.47M | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2017-06-30 | $18.00K | $201.37M | $-7.00K | $-171.88M | $29.49M | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2017-03-31 | $17.00K | $199.26M | (m) | $-166.28M | $33.00M | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2016-12-31 | $17.00K | $198.20M | (m) | $-159.78M | $38.44M | (m) | (m) | $0.00 | 12 month · $3.34M | (m) | 12 month · $197.00K |
| 2016-09-30 | $17.00K | $197.31M | $8.00K | $-152.81M | $44.45M | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2016-06-30 | $16.00K | $196.61M | $10.00K | $-145.71M | $50.92M | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2016-03-31 | $16.00K | $195.53M | $12.00K | $-137.80M | $57.75M | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2015-12-31 | $16.00K | $194.65M | $-11.00K | $-131.25M | $63.41M | (m) | (m) | $0.00 | 12 month · $2.16M | (m) | 12 month · $88.00K |
| 2015-09-30 | $16.00K | $193.92M | $6.00K | $-124.91M | $69.03M | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2015-06-30 | $16.00K | $193.27M | $3.00K | $-119.53M | $73.76M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $16.00K | $192.73M | (m) | $-114.45M | $78.29M | (m) | (m) | $0.00 | (m) | (m) | (m) |
| 2014-12-31 | $16.00K | $192.32M | $-6.00K | $-109.87M | $82.46M | (m) | (m) | $0.00 | 12 month · $459.00K | 12 month · $1.43M | 12 month · $59.00K |
| 2014-09-30 | (m) | (m) | $-11.00K | $-116.54M | $-116.55M | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | (m) | (m) | (m) | $-100.51M | $-100.51M | (m) | (m) | $0.00 | 12 month · $155.00K | (m) | 12 month · $19.00K |
| 2012-12-31 | (m) | (m) | (m) | (m) | $-86.66M | (m) | (m) | (m) | 12 month · $110.00K | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | $-72.66M | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| ANAVEX LIFE SCIENCES CORP. (AVXL) | United States | $0.218B | -18.37 |
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |